Cureline Baltic

Cureline Baltic is part of a global translational and precision medicine CRO providing human biospecimen (HBS) biobanking, preclinical animal research and laboratory services for accelerated drug R&D and Dx development.
Our mission is to support our clients' drug discovery pipeline by providing advanced scientific knowledge, access to innovation, and collaborations with leading biopharmaceutical companies and universities.
Located in Vilnius, Lithuania, our administrative office, and state-of-the-art animal facility serve as the hub for our comprehensive suite of high-quality biological services.
Our expertise spans preclinical in vitro, ex vivo, and in vivo models, with a strong emphasis on small animal studies and bioanalytical services.
By working closely with our clients, we develop custom preclinical research strategies in the areas of oncology, immunology, inflammation, hematology, cardiovascular conditions, metabolic conditions, infectious diseases, etc.
In addition, we specialize in human biospecimen (HBS) procurement, encompassing the acquisition of fresh, frozen, and fixed tissues and biofluids.
We cover all aspects from study design, regulatory affairs, clinical network management, HBS collection and analyses, and full-scale logistics. By providing our services we contribute to the identification of novel drug targets, biomarker discovery and development. This aids better drug efficacy and safety, and also creation of clinically relevant diagnostic tests.
  1. Preclinical Study Design

  2. Custom Animal Models

  3. Laboratory Network Management

  4. Biospecimen Procurement & Analysis

  5. Bioanalytical Laboratory Services

  6. Regulatory Affairs

Global Cureline Group - HBS Translational Services

As a part of a global Cureline Group, UAB Cureline Baltic provides access to human biospecimen acquisition (, translational histopathology (CBP), molecular and cell assay services (CMS) in the USA, the EU and worldwide. We support human and animal tissue management, offer standard and custom cell-based assays, manipulation with biofluid cellular fractions and tissue components (cells, DNA, RNA, proteins), and comprehensive molecular analyses (proteomics, glycoproteomics, genomics).